COVID-19 Pandemic and Equal Access to Vaccines.

COVAX COVID-19 equity public health vaccination

Journal

Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355

Informations de publication

Date de publication:
21 May 2021
Historique:
received: 16 04 2021
revised: 06 05 2021
accepted: 18 05 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 3 6 2021
Statut: epublish

Résumé

The COVID-19 pandemic has evidenced the chronic inequality that exists between populations and communities as regards global healthcare. Vaccination, an appropriate tool for the prevention of infection, should be guaranteed by means of proportionate interventions to defeat such inequality in populations and communities affected by a higher risk of infection. Equitable criteria of justice should be identified and applied with respect to access to vaccination and to the order in which it should be administered. This article analyzes, as regards the worldwide distribution of anti-COVID-19 vaccines, the various ways the principle of equity has been construed and applied or even overlooked. The main obstacle to equal access to vaccines is vaccine nationalism. The perception of equity varies with the differing reference values adopted. Adequate response to needs appears to be the principal rule for achieving the criterion of equity in line with distributive justice. Priorities must be set equitably based on rational parameters in accordance with current needs. The entire process must be governed by transparency, from parameter identification to implementation. The issue of equal access to vaccination affects the entire world population, necessitating specific protective interventions. In light of this, the World Health Organization (WHO) has devised the COVAX plan to ensure that even the poorest nations of the world receive the vaccine; certain initiatives are also supported by the European Union (EU). This pandemic has brought to the fore the need to build a culture of equitable relationships both in each country's own domain and with the rest of the world.

Identifiants

pubmed: 34063863
pii: vaccines9060538
doi: 10.3390/vaccines9060538
pmc: PMC8224034
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J Natl Med Assoc. 2021 Feb 16;:
pubmed: 33608084
BMJ Glob Health. 2021 Jan;6(1):
pubmed: 33479019
N Engl J Med. 2020 May 21;382(21):2049-2055
pubmed: 32202722
Br J Anaesth. 2020 Jul;125(1):e181-e183
pubmed: 32416993
Epidemiol Prev. 2020 Sep-Dec;44(5-6 Suppl 2):271-281
pubmed: 33412819
Pol Arch Intern Med. 2020 May 29;130(5):466-472
pubmed: 32356639
BMJ. 2021 Feb 1;372:n292
pubmed: 33526414
Lancet. 2021 Jan 23;397(10271):265-266
pubmed: 33485436
Environ Syst Decis. 2021 Mar 8;:1-3
pubmed: 33717825
Int J Environ Res Public Health. 2021 Jan 09;18(2):
pubmed: 33435324
BMJ Glob Health. 2020 Nov;5(11):
pubmed: 33257418
Int J Infect Dis. 2021 Apr;105:448-451
pubmed: 33652065
N Engl J Med. 2020 May 14;382(20):1873-1875
pubmed: 32187459
Environ Res. 2020 Dec;191:110155
pubmed: 32871151
J Korean Med Sci. 2021 Feb 22;36(7):e59
pubmed: 33619920
Ethical Theory Moral Pract. 2021 Feb 14;:1-16
pubmed: 33613085
Milbank Q. 2021 Jun;99(2):426-449
pubmed: 33650737
Glob Health Action. 2021 Jan 1;14(1):1892309
pubmed: 33627051
Milbank Q. 2021 Jun;99(2):450-466
pubmed: 33295679
Epidemiol Prev. 2020 Sep-Dec;44(5-6 Suppl 2):244-251
pubmed: 33412816
BMJ. 2020 Dec 15;371:m4735
pubmed: 33323384
BMJ. 2020 Dec 15;371:m4704
pubmed: 33323388
Science. 2020 Aug 14;369(6505):749
pubmed: 32792371
Results Phys. 2021 Feb;21:103811
pubmed: 33520630
Science. 2020 Sep 11;369(6509):1309-1312
pubmed: 32883884
Healthcare (Basel). 2020 Dec 25;9(1):
pubmed: 33375544
BMJ. 2020 Dec 15;371:m4750
pubmed: 33323376
Int J Infect Dis. 2021 Apr;105:243-244
pubmed: 33640569
BMJ. 2020 Oct 5;371:m3795
pubmed: 33020072
J Med Ethics. 2021 Feb 15;:
pubmed: 33589473
BMJ. 2021 Jan 5;372:m4853
pubmed: 33402340
Public Adm Rev. 2020 Jun 22;:
pubmed: 32836465
Swiss Med Wkly. 2021 Mar 13;151:w20488
pubmed: 33715145
Glob Public Health. 2021 Mar;16(3):319-339
pubmed: 33317389
Rev Panam Salud Publica. 2020 May 29;44:e70
pubmed: 32523608
MEDICC Rev. 2020 Oct;22(4):10-15
pubmed: 33295312
J Public Health (Oxf). 2021 Jun 7;43(2):e346-e347
pubmed: 33690834
Curr Opin Immunol. 2021 Apr 9;71:13-20
pubmed: 33845349
Int J Health Serv. 2021 Jul;51(3):311-324
pubmed: 33650453
Public Health Pract (Oxf). 2021 Nov;2:100096
pubmed: 33615282
Int J Environ Res Public Health. 2021 Mar 03;18(5):
pubmed: 33802378
J Travel Med. 2021 Mar 05;:
pubmed: 33690836
J Med Ethics. 2020 Dec 11;:
pubmed: 33310742
J Med Ethics. 2020 Aug;46(8):526-530
pubmed: 32546657
Int J Environ Res Public Health. 2020 Dec 05;17(23):
pubmed: 33291364

Auteurs

Matteo Bolcato (M)

Legal Medicine, University of Padua, via G. Falloppio 50, 35121 Padua, Italy.

Daniele Rodriguez (D)

Legal Medicine, University of Padua, via G. Falloppio 50, 35121 Padua, Italy.

Alessandro Feola (A)

Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", via Luciano Armanni 5, 80138 Naples, Italy.

Giulio Di Mizio (G)

Forensic Medicine, Department of Law, "Magna Graecia" University of Catanzaro, 88100 Catanzaro, Italy.

Alessandro Bonsignore (A)

Department of Health Sciences, Section of Legal and Forensic Medicine, University of Genova, 16132 Genova, Italy.

Rosagemma Ciliberti (R)

Department of Health Sciences, Section of History of Medicine and Bioethics, University of Genova, 16132 Genova, Italy.

Camilla Tettamanti (C)

Department of Health Sciences, Section of Legal and Forensic Medicine, University of Genova, 16132 Genova, Italy.

Marco Trabucco Aurilio (M)

Department of Medicine and Health Sciences "V. Tiberio," University of Molise, 86100 Campobasso, Italy.

Anna Aprile (A)

Legal Medicine, University of Padua, via G. Falloppio 50, 35121 Padua, Italy.

Classifications MeSH